Danazol

NEW ORLEANS — In this video, Aaron T. Gerds, MD, MS, assistant professor at the Cleveland Clinic Taussig Cancer Institute, discusses updated results from the Momentum phase 3 study presented at the ASH Annual Meeting and Exposition.

CHICAGO — In a video interview, Aaron Thomas Gerds, MD, MS, discussed the efficacy and safety of momelotinib in a subset of patients with thrombocytopenic myelofibrosis from the MOMENTUM study, which was presented at ASCO Annual Meeting.

CHICAGO — Aaron Thomas Gerds, MD, MS, of Cleveland Clinic Taussig Cancer Institute and Case Comprehensive Cancer Center, spoke with Healio about topline results from the MOMENTUM study presented at ASCO Annual Meeting.